|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pritchard CC and Grady WM: Colorectal
cancer molecular biology moves into clinical practice. Gut.
60:116–129. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Augestad KM, Bakaki PM, Rose J, Crawshaw
BP, Lindsetmo RO, Dørum LM, Koroukian SM and Delaney CP: Metastatic
spread pattern after curative colorectal cancer surgery. A
retrospective, longitudinal analysis. Cancer Epidemiol. 39:734–744.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Luo HY and Xu RH: Predictive and
prognostic biomarkers with therapeutic targets in advanced
colorectal cancer. World J Gastroenterol. 20:3858–3874. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hu YF, Lüscher B, Admon A, Mermod N and
Tjian R: Transcription factor AP-4 contains multiple dimerization
domains that regulate dimer specificity. Genes Dev. 4:1741–1752.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Atchley WR and Fitch WM: A natural
classification of the basic helix-loop-helix class of transcription
factors. Proc Natl Acad Sci USA. 94:5172–5176. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jung P and Hermeking H: The c-MYC-AP4-p21
cascade. Cell Cycle. 8:982–989. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim MY, Jeong BC, Lee JH, Kee HJ, Kook H,
Kim NS, Kim YH, Kim JK, Ahn KY and Kim KK: A repressor complex, AP4
transcription factor and geminin, negatively regulates expression
of target genes in nonneuronal cells. Proc Natl Acad Sci USA.
103:13074–13079. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jackstadt R and Hermeking H: AP4 is
required for mitogen- and c-MYC-induced cell cycle progression.
Oncotarget. 5:7316–7327. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jackstadt R, Jung P and Hermeking H: AP4
directly downregulates p16 and p21 to suppress senescence and
mediate transformation. Cell Death Dis. 4:e7752013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jung P, Menssen A, Mayr D and Hermeking H:
AP4 encodes a c-MYC-inducible repressor of p21. Proc Natl Acad Sci
USA. 105:15046–15051. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jackstadt R, Röh S, Neumann J, Jung P,
Hoffmann R, Horst D, Berens C, Bornkamm GW, Kirchner T, Menssen A
and Hermeking H: AP4 is a mediator of epithelial-mesenchymal
transition and metastasis in colorectal cancer. J Exp Med.
210:1331–1350. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Amin S, Kumar A, Nilchi L, Wright K and
Kozlowski M: Breast cancer cells proliferation is regulated by
tyrosine phosphatase SHP1 through c-jun N-terminal kinase and
cooperative induction of RFX-1 and AP-4 transcription factors. Mol
Cancer Res. 9:1112–1115. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xinghua L, Bo Z, Yan G, Lei W, Changyao W,
Qi L, Lin Y, Kaixiong T, Guobin W and Jianying C: The
overexpression of AP-4 as a prognostic indicator for colorectal
carcinoma. Med Oncol. 29:871–877. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hu BS, Zhao G, Yu HF, Chen K, Dong JH and
Tan JW: High expression of AP-4 predicts poor prognosis for
hepatocellular carcinoma after curative hepatectomy. Tumour Biol.
34:271–276. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Edge SB, Byrd SR, Compton CC, et al: AJCC
cancer staging manual. 7th edition. Springer-Verlag; New York (NY):
pp. 143–164. 2010
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mermod N, Williams TJ and Tjian R:
Enhancer binding factors AP-4 and AP-1 act in concert to activate
SV40 late transcription in vitro. Nature. 332:557–561. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tsujimoto K, Ono T, Sato M, Nishida T,
Oguma T and Tadakuma T: Regulation of the expression of caspase-9
by the transcription factor activator protein-4 in
glucocorticoid-induced apoptosis. J Biol Chem. 280:27638–27644.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu X, Zhang B, Guo Y, Liang Q, Wu C, Wu
L, Tao K, Wang G and Chen J: Down-regulation of AP-4 inhibits
proliferation, induces cell cycle arrest and promotes apoptosis in
human colorectal cancer cells. PLoS One. 7:e370962012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zirbes TK, Baldus SE, Moenig SP, Nolden S,
Kunze D, Shafizadeh ST, Schneider PM, Thiele J, Hoelscher AH and
Dienes HP: Prognostic impact of p21/waf1/cip1 in colorectal cancer.
Int J Cancer. 89:14–18. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bunz F, Dutriaux A, Lengauer C, Waldman T,
Zhou S, Brown JP, Sedivy JM, Kinzler KW and Vogelstein B:
Requirement for p53 and p21 to sustain G2 arrest after DNA damage.
Science. 282:1497–1501. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cancer Genome Atlas Network, . Muzny DM,
Bainbridge MN, Chang K, Dinh HH, Drummond JA, Fowler G, Kovar CL,
Lewis L, Morgan MB, et al: Comprehensive molecular characterization
of human colon and rectal cancer. Nature. 487:330–337. 2012.
View Article : Google Scholar : PubMed/NCBI
|
